Sensus Healthcare, Inc. - Income Statement (TTM)

Sensus Healthcare, Inc.
US ˙ NasdaqCM ˙ US81728J1097

Income Statement (TTM)

Sensus Healthcare, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 13 10 11 15 19 27 34 41 44 45 38 30 25 24 32 36 41 42 39 38
Change (%) -26.29 14.52 38.65 25.67 41.50 26.88 19.40 8.51 0.18 -15.55 -20.08 -17.01 -2.15 29.70 14.89 13.59 1.21 -5.55 -4.87
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6 4 5 6 8 10 12 14 14 15 14 12 10 10 13 14 16 17 17 18
Change (%) -21.50 11.88 31.66 21.58 29.71 16.96 14.86 6.02 4.09 -9.37 -14.19 -10.59 -0.17 21.35 15.20 11.69 7.58 -0.06 3.44
% of Revenue 42.43 45.19 44.15 41.92 40.56 37.18 34.27 32.97 32.21 33.47 35.92 38.56 41.55 42.39 39.66 39.77 39.10 41.56 43.98 47.82
Gross Operating Profit 7 5 6 9 11 17 23 27 30 30 24 18 15 14 19 22 25 24 22 20
Change (%) -29.82 16.71 44.17 28.62 49.54 32.75 21.77 9.73 -1.68 -18.65 -23.38 -21.05 -3.56 35.85 14.68 14.85 -2.88 -9.45 -11.40
% of Revenue 57.57 54.81 55.85 58.08 59.44 62.82 65.73 67.03 67.79 66.53 64.08 61.44 58.45 57.61 60.34 60.23 60.90 58.44 56.02 52.18
SG&A 11 9 8 9 9 9 10 10 11 11 12 12 12 11 10 10 10 12 14 14
Change (%) -13.02 -11.59 7.69 2.83 3.32 4.78 1.62 7.02 5.48 8.57 0.52 -1.34 -11.82 -5.70 -3.43 0.83 22.69 12.74 5.84
% of Revenue 82.52 97.37 75.16 58.38 47.77 34.88 28.81 24.51 24.18 25.46 32.73 41.17 48.94 44.11 32.07 26.95 23.93 29.00 34.62 38.52
R&D 4 4 4 3 3 3 4 3 3 3 4 4 4 4 4 4 3 4 6 7
Change (%) -2.50 -13.56 -6.20 -5.87 8.29 1.95 -2.77 0.06 1.53 10.69 -0.16 8.76 -11.57 -4.68 1.25 -6.14 26.53 39.85 10.26
% of Revenue 32.82 43.42 32.77 22.17 16.60 12.71 10.21 8.31 7.67 7.77 10.18 12.72 16.67 15.07 11.08 9.76 8.07 10.08 14.93 17.31
OpEx 20 18 17 19 20 23 25 27 28 30 30 28 27 25 26 28 29 34 37 39
Change (%) -13.11 -6.35 11.65 7.67 14.31 9.70 7.20 5.64 4.31 -0.19 -6.27 -3.81 -7.27 5.74 6.12 5.58 14.81 9.53 5.42
% of Revenue 157.78 185.98 152.08 122.47 104.93 84.76 73.29 65.80 64.06 66.70 78.83 92.45 107.16 101.57 82.80 76.48 71.09 80.65 93.52 103.64
Operating Income -8 -8 -6 -3 -1 4 9 14 16 15 8 2 -2 -0 5 9 12 8 3 -1
Change (%) 9.69 -30.63 -40.18 -72.43 -537.37 122.45 52.89 14.03 -7.18 -46.32 -71.51 -178.79 -78.62 -1,525.13 57.09 39.63 -32.25 -68.39 -153.50
% of Revenue -57.78 -85.98 -52.08 -22.47 -4.93 15.24 26.71 34.20 35.94 33.30 21.17 7.55 -7.16 -1.57 17.20 23.52 28.91 19.35 6.48 -3.64
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -17.65 -0.00 -92.86 -0.00 -0.00 50.00
% of Revenue -0.13 -0.15 -0.13 -0.01 -0.01 -0.01 -0.00 -0.01
Net Income -7 -7 -4 -2 -0 4 21 25 27 24 6 2 -1 0 5 7 9 7 2 -1
Change (%) 0.31 -36.16 -52.59 -91.25 -2,375.69 417.02 17.86 6.51 -9.31 -74.06 -62.09 -137.58 -154.13 859.38 42.81 40.12 -28.61 -72.91 -147.08
% of Revenue -52.45 -71.38 -39.79 -13.61 -0.95 15.23 62.07 61.27 60.14 54.44 16.72 7.93 -3.59 1.99 14.70 18.27 22.54 15.90 4.56 -2.26

Source: Capital IQ

Other Listings
DE:5TX €2.68
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista